This brand name is authorized in Estonia, Malta, Poland, Turkey
The drug PROPYCIL contains one active pharmaceutical ingredient (API):
|
1
Propylthiouracil
UNII 721M9407IY - PROPYLTHIOURACIL
|
|
Propylthiouracil is an antithyroid drug that depresses the formation of thyroid hormone. This is effected by interference both with the incorporation of iodine into tyrosyl residues and the coupling of such residues to form iodothyronines. Propylthiouracil achieves these actions by the inhibition of the enzyme peroxidase. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| H03BA02 | Propylthiouracil | H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03B Antithyroid preparations → H03BA Thiouracils |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1774199 |
| Country: MT | Medicines Authority | Identifier(s): AA729/29001 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100273930 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699559010039, 8699559010046 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
